Evidence map›Paper›PMID 36580091›Full record

ReviewHerzschrittmachertherapie & Elektrophysiologie2023

[Atrial fibrillation in athletes : Prevalence, diagnosis, and treatment].

Agne Adukauskaite, Markus Stühlinger

Open access · hybridAbstract readEnglish AbstractReview
In one paragraph

Review in Herzschrittmachertherapie & Elektrophysiologie, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Agne AdukauskaiteUniv. Klinik für Innere Medizin III, Kardiologie und Angiologie, Medizinische Universität Innsbruck, Tirol-Kliniken, Anichstraße 35, 6020, Innsbruck, Österreich.
Markus StühlingerUniv. Klinik für Innere Medizin III, Kardiologie und Angiologie, Medizinische Universität Innsbruck, Tirol-Kliniken, Anichstraße 35, 6020, Innsbruck, Österreich. markus.stuehlinger@tirol-kliniken.at.
Tirol Kliniken · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of atrial fibrillation (AF) is increased by an average of approximately 2.5-fold in recreational and elite athletes, depending on the intensity of exercise. It is, however, difficult to determine the exact duration or intensity of exercise that increases the risk of AF. The pathophysiological mechanisms of AF in athletes are a combination of pulmonary vein ectopy as a trigger, myocardial changes such as fibrosis and remodeling processes, and modulators such as changes in the autonomic nervous system. However, gastroesophageal reflux also seems to play an important role. MATERIAL AND

methodsThe classic AF diagnosis is performed by means of 12-lead or Holter ECG; arrhythmia recordings via chest belts and pulse watches are not sufficient for the differentiation of the arrhythmia. However, wearables with the capability of ECG recording can also be used for AF screening. The first AF documentation in an athlete should be followed by cessation of physical exercise and initiation of detailed cardiac diagnostics. Thereafter, evaluation of oral anticoagulation is important. Long-term antiarrhythmic therapies are usually not tolerated or desired by athletes. Thus, valuable therapeutic options are either a "pill in the pocket" therapy with antiarrhythmic drugs or catheter ablation.

Indexed as

Atrial FibrillationCatheter AblationAnti-Arrhythmia AgentsAthletesExerciseHumansPrevalenceTreatment OutcomeAnti-Arrhythmia AgentsAnti-arrhythmic drugsAthletesCatheter ablationRhythm disturbancesSport

Identifiers

PMID36580091
PMCPMC9950188
OpenAlexW4313242229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.